COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,757 Articles (22,502 medRxiv, 8,255 bioRxiv)

Most recent first Previous |  Page 433: Articles 4321-4330  | Next

An SEIDR Model for the Early Spread of COVID-19
Cao, T.
10.1101/2023.02.17.23286115 — Posted: 2023-02-21
A robust Platform for Integrative Spatial Multi-omics Analysis to Map Immune Responses to SARS-CoV-2 infection in Lung Tissues
Tan, X., Grice, L. F., Tran, M., Mulay, O., Monkman, J., Blick, T., Vo, T. Q. A., Almeida, A. C. S. F., Junior, J. d. S. M., de Moura, K. F., Machado-Souza, C., Souza-Fonseca-Guimaraes, P., Baena, C. P., de Noronha, L., Guimaraes, F. S. F., Luu, H. N., Drennon, T., Williams, S., Stern, J., Uytingco, C., Cooper, C., Short, K., Belz, G., Souza-Fonseca-Guimaraes, F., Kulasinghe, A., Nguyen, Q.
10.1101/2023.02.19.529128 — Posted: 2023-02-20
Genetic consequences of effective and suboptimal dosing with mutagenic drugs in a hamster model of SARS-CoV-2 infection
Illingworth, C., Guerra-Assuncao, J. A., Gregg, S., Charles, O. J., Pang, J., Roy, S., Abdelnabi, R., Neyts, J., Breuer, J.
10.1101/2023.02.20.529243 — Posted: 2023-02-20
Antibody-mediated cell entry of SARS-CoV-2
Kibria, M. G., Lavine, C. L., Tang, W., Wang, S., Gao, H., Shi, W., Zhu, H., Voyer, J., Rits-Volloch, S., Keerti, F., Bi, C., Peng, H., Wesemann, D., Lu, J., Xie, H., Seaman, M. S., Chen, B.
10.1101/2023.02.20.529249 — Posted: 2023-02-20
Bovine milk glycoproteins inhibit SARS-CoV-2 and influenza virus co-infection
Yu, H., Chen, W., Shu, J., Wu, X., Quan, J., Cheng, H., Bao, X., Wu, D., Wang, X., Li, Z.
10.1101/2023.02.20.529234 — Posted: 2023-02-20
Discovery of a novel merbecovirus cDNA clone contaminating agricultural rice sequencing datasets from Wuhan, China
Jones, A., Zhang, D., Massey, S. E., Deigin, Y., Nemzer, L. R., Quay, S. C.
10.1101/2023.02.12.528210 — Posted: 2023-02-20
Tracking and curating putative SARS-CoV-2 recombinants with RIVET
Smith, K., Ye, C., Turakhia, Y.
10.1101/2023.02.17.529036 — Posted: 2023-02-19
Protective effect of plasma neutralization from prior SARS-CoV-2 Omicron infection against BA.5 subvariant symptomatic reinfection
Chen, X., Xu, Y., Xie, Y., Song, W., Hu, Y., Yisimayi, A., Shao, F., Geng, L., Wang, Y., Gao, H., Shi, Y., Zhang, S., Jin, R., Shen, Z., Cao, Y. R.
10.1101/2023.02.14.527605 — Posted: 2023-02-19
Mortality by cause of death in Brazil: effects of the COVID-19 pandemic and contribution to changes in life expectancy at birth
Fernandes, F., Turra, C. M., Franca, G. V. A., Castro, M. C.
10.1101/2023.02.13.23285842 — Posted: 2023-02-19
Mental health symptoms in Latin America during the first year of COVID-19 pandemic: a meta-analysis of prevalence and potential moderator variables
Torrente, F., Ailan, D., Del Cerro, E., Del Negro, J., Gorodetzky, B., Slonimschik, D., Cetkovich-Bakmas, M., Lopez, P.
10.1101/2023.02.18.23286126 — Posted: 2023-02-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).